[1] LIU S, SHEN G, LI W.Structural and cellular basis of vitamin K antagonism[J]. J Thromb Haemost, 2022, 20(9): 1971-1983. [2] WANG M, ZERAATKAR D, OBEDA M, et al.Drug-drug interactions with warfarin: A systematic review and meta-analysis[J]. Br J Clin Pharmacol, 2021, 87(11): 4051-4100. [3] TAN C, LEE S.Warfarin and food, herbal or dietary supplement interactions: a systematic review[J]. Br J Clin Pharmacol, 2021, 87(2): 352-374. [4] VILLA ZL, HANSTEN PD, PANIC J, et al.Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis[J]. Thromb Haemost, 2020, 120(7): 1066-1074. [5] LOPES RD, HOROWITZ JD, GARCIA DA, et al.Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility[J]. Blood, 2011, 118(24): 6269-6273. [6] HUGHES GJ, PATEL PN, SAXENA N.Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy[J]. Pharmacotherapy, 2011, 31(6): 591-597. [7] PINSON GM, BEALL JW, KYLE JA.A review of warfarin dosing with concurrent acetaminophen therapy[J]. J Pharm Pract, 2013, 26(5): 518-521. [8] WISHART DS, FEUNANG YD, GUO AC, et al.DrugBank 5.0: a major update to the DrugBank database for 2018[J]. Nucleic Acids Res, 2017, 46(D1): D1074-D1082. [9] ZAFAR S, ASHRAF MM, ALI A, et al.Effect of caffeine on anti-clotting activity of warfarin in healthy male albino rabbits[J]. Pak J Pharm Sci, 2018, 31(2Suppl): 611-616. [10] NARANJO CA, BUSTO U, SELLERS EM, et al.A method for estimating the probability of adverse drug reactions[J]. Clin Pharmacol Ther, 1981, 30(2): 239-245. [11] CHUANTAO C, HUIHUI F, XIAOJUN F, et al.Individualized anticoagulant therapy for warfarin in a patient with poor metabolism[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(12): 939-942. |